{"date":"2025-09-03","count":3,"source":"公開資訊觀測站（MOPS）","attribution":"引用請註明：Drugnews 事實帳本（https://drugnews.com.tw/filings/）與公開資訊觀測站原始公告","records":[{"id":"tw-6550-2025-09-03-1705-1qj44hg","company_id":"6550","company":"北極星藥業-KY","market":"上市","industry":"生技醫療","date":"2025-09-03","time":"17:05:53","subject":"公告本公司財務主管異動","clause":"","fact_date":"","cite_as":"公開資訊觀測站重大訊息：北極星藥業-KY（6550），2025-09-03 17:05，「公告本公司財務主管異動」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-6848-2025-09-03-1641-18xuqm9","company_id":"6848","company":"拉法醫","market":"興櫃","industry":"生技醫療","date":"2025-09-03","time":"16:41:57","subject":"公告本公司董事長訂定114年上半年度現金股利除息基準日","clause":"第31款","fact_date":"2025-09-03","cite_as":"公開資訊觀測站重大訊息：拉法醫（6848），2025-09-03 16:41，「公告本公司董事長訂定114年上半年度現金股利除息基準日」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-6785-2025-09-03-1431-19pbwrr","company_id":"6785","company":"昱展新藥","market":"上櫃","industry":"生技醫療","date":"2025-09-03","time":"14:31:27","subject":"公告本公司取得「SUSTAINED-RELEASE BUPRENORPHINEFORMULATIONS」菲律賓專利核准通知書。","clause":"第53款","fact_date":"2025-09-03","cite_as":"公開資訊觀測站重大訊息：昱展新藥（6785），2025-09-03 14:31，「公告本公司取得「SUSTAINED-RELEASE BUPRENORPHINEFORMULATIONS」菲律賓專利核准通」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"}]}